Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of live attenuated hepatitis A vaccine in overweight and obese children/adolescent/young adult
TCTR20191230001Phase 4Recruiting
- Sponsor
- Biogenetech
- Start
- Nov 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis A vaccine (live, attenuated) in hepatitis A (HAV), sponsored by Biogenetech. Started Nov 2019; status: recruiting.
02
Drugs
hepatitis A vaccine (live, attenuated)
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on TCTR20191230001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191230001.